References
Cunha BA, Mohan SS, Hamid N, McDermott BP, Daniels P (2007) Cost-ineffectiveness of serum vancomycin levels. Eur J Clin Microbiol Infect Dis 26:509–511
Anderson BJ, Allegaert K, van den Anker JN, Cossey V, Holford NH (2007) Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 63:75–84
Van den Anker JN (1996) Pharmacokinetics and renal function in preterm infants. Acta Paediatr 85:1393–1399
Allegaert K, Anderson BJ, Cossey V, Holford NH (2006) Limited predictability of amikacin clearance in extreme premature neonates at birth. Br J Clin Pharmacol 61:39–48
de Hoog M, Mouton JW, van den Anker JN (2004) Vancomycin: pharmacokinetics and administration regimens in neonates. Clin Pharmacokinet 43:417–440
Acknowledgements
The clinical research of K. Allegaert is supported by the Clinical Research Fund of the University Hospital, Leuven, Belgium.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allegaert, K., van den Anker, J.N. Predictability of vancomycin pharmacokinetics in neonates. Eur J Clin Microbiol Infect Dis 26, 847–848 (2007). https://doi.org/10.1007/s10096-007-0367-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-007-0367-4